Oxetanyl Amino Acids for Peptidomimetics
Peptides are important in the drug discovery process. In analogy to nonpeptidic small-molecule counterparts, they can sometimes suffer from disadvantages such as their low bioavailability and poor metabolic stability. Herein, we report the synthesis of new oxetanyl dipeptides and their incorporation...
Gespeichert in:
| Veröffentlicht in: | Organic letters 2017-05, Vol.19 (10), p.2510-2513 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2513 |
|---|---|
| container_issue | 10 |
| container_start_page | 2510 |
| container_title | Organic letters |
| container_volume | 19 |
| creator | Möller, Guido P Müller, Steffen Wolfstädter, Bernd T Wolfrum, Susanne Schepmann, Dirk Wünsch, Bernhard Carreira, Erick M |
| description | Peptides are important in the drug discovery process. In analogy to nonpeptidic small-molecule counterparts, they can sometimes suffer from disadvantages such as their low bioavailability and poor metabolic stability. Herein, we report the synthesis of new oxetanyl dipeptides and their incorporation into Leu-enkephalin analogues as proof-of-principle studies. The modular approach that is described enables the incorporation of a variety of oxetanyl amino acids into potential peptide therapeutics. |
| doi_str_mv | 10.1021/acs.orglett.7b00745 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1894518254</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1894518254</sourcerecordid><originalsourceid>FETCH-LOGICAL-a345t-2539ea208b1eae2c38b85690f401e437a5a0865a249eb799afcf16b90ec682bb3</originalsourceid><addsrcrecordid>eNp9kMtqwzAQRUVpadK0X1AoXmbjRE9bWobQFwTSRbsWkjIuDraVSjI0f1-HuF2WWcww3HuHOQjdE7wgmJKlcXHhw2cDKS1Ki3HJxQWaEkFZXmJBL__mAk_QTYx7jMmwUddoQiUXaqgpmm-_IZnu2GSrtu58tnL1LmaVD9kbHFK9823dQqpdvEVXlWki3I19hj6eHt_XL_lm-_y6Xm1yw7hIORVMgaFYWgIGqGPSSlEoXHFMgLPSCINlIQzlCmyplKlcRQqrMLhCUmvZDM3PuYfgv3qISbd1dNA0pgPfR02k4oJIKvggZWepCz7GAJU-hLo14agJ1idEekCkR0R6RDS4HsYDvW1h9-f5ZTIIlmfByb33feiGf_-N_AF1RHQQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1894518254</pqid></control><display><type>article</type><title>Oxetanyl Amino Acids for Peptidomimetics</title><source>ACS Publications</source><creator>Möller, Guido P ; Müller, Steffen ; Wolfstädter, Bernd T ; Wolfrum, Susanne ; Schepmann, Dirk ; Wünsch, Bernhard ; Carreira, Erick M</creator><creatorcontrib>Möller, Guido P ; Müller, Steffen ; Wolfstädter, Bernd T ; Wolfrum, Susanne ; Schepmann, Dirk ; Wünsch, Bernhard ; Carreira, Erick M</creatorcontrib><description>Peptides are important in the drug discovery process. In analogy to nonpeptidic small-molecule counterparts, they can sometimes suffer from disadvantages such as their low bioavailability and poor metabolic stability. Herein, we report the synthesis of new oxetanyl dipeptides and their incorporation into Leu-enkephalin analogues as proof-of-principle studies. The modular approach that is described enables the incorporation of a variety of oxetanyl amino acids into potential peptide therapeutics.</description><identifier>ISSN: 1523-7060</identifier><identifier>EISSN: 1523-7052</identifier><identifier>DOI: 10.1021/acs.orglett.7b00745</identifier><identifier>PMID: 28459595</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><ispartof>Organic letters, 2017-05, Vol.19 (10), p.2510-2513</ispartof><rights>Copyright © 2017 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a345t-2539ea208b1eae2c38b85690f401e437a5a0865a249eb799afcf16b90ec682bb3</citedby><cites>FETCH-LOGICAL-a345t-2539ea208b1eae2c38b85690f401e437a5a0865a249eb799afcf16b90ec682bb3</cites><orcidid>0000-0003-1472-490X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acs.orglett.7b00745$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acs.orglett.7b00745$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2751,27055,27903,27904,56716,56766</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28459595$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Möller, Guido P</creatorcontrib><creatorcontrib>Müller, Steffen</creatorcontrib><creatorcontrib>Wolfstädter, Bernd T</creatorcontrib><creatorcontrib>Wolfrum, Susanne</creatorcontrib><creatorcontrib>Schepmann, Dirk</creatorcontrib><creatorcontrib>Wünsch, Bernhard</creatorcontrib><creatorcontrib>Carreira, Erick M</creatorcontrib><title>Oxetanyl Amino Acids for Peptidomimetics</title><title>Organic letters</title><addtitle>Org. Lett</addtitle><description>Peptides are important in the drug discovery process. In analogy to nonpeptidic small-molecule counterparts, they can sometimes suffer from disadvantages such as their low bioavailability and poor metabolic stability. Herein, we report the synthesis of new oxetanyl dipeptides and their incorporation into Leu-enkephalin analogues as proof-of-principle studies. The modular approach that is described enables the incorporation of a variety of oxetanyl amino acids into potential peptide therapeutics.</description><issn>1523-7060</issn><issn>1523-7052</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kMtqwzAQRUVpadK0X1AoXmbjRE9bWobQFwTSRbsWkjIuDraVSjI0f1-HuF2WWcww3HuHOQjdE7wgmJKlcXHhw2cDKS1Ki3HJxQWaEkFZXmJBL__mAk_QTYx7jMmwUddoQiUXaqgpmm-_IZnu2GSrtu58tnL1LmaVD9kbHFK9823dQqpdvEVXlWki3I19hj6eHt_XL_lm-_y6Xm1yw7hIORVMgaFYWgIGqGPSSlEoXHFMgLPSCINlIQzlCmyplKlcRQqrMLhCUmvZDM3PuYfgv3qISbd1dNA0pgPfR02k4oJIKvggZWepCz7GAJU-hLo14agJ1idEekCkR0R6RDS4HsYDvW1h9-f5ZTIIlmfByb33feiGf_-N_AF1RHQQ</recordid><startdate>20170519</startdate><enddate>20170519</enddate><creator>Möller, Guido P</creator><creator>Müller, Steffen</creator><creator>Wolfstädter, Bernd T</creator><creator>Wolfrum, Susanne</creator><creator>Schepmann, Dirk</creator><creator>Wünsch, Bernhard</creator><creator>Carreira, Erick M</creator><general>American Chemical Society</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1472-490X</orcidid></search><sort><creationdate>20170519</creationdate><title>Oxetanyl Amino Acids for Peptidomimetics</title><author>Möller, Guido P ; Müller, Steffen ; Wolfstädter, Bernd T ; Wolfrum, Susanne ; Schepmann, Dirk ; Wünsch, Bernhard ; Carreira, Erick M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a345t-2539ea208b1eae2c38b85690f401e437a5a0865a249eb799afcf16b90ec682bb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Möller, Guido P</creatorcontrib><creatorcontrib>Müller, Steffen</creatorcontrib><creatorcontrib>Wolfstädter, Bernd T</creatorcontrib><creatorcontrib>Wolfrum, Susanne</creatorcontrib><creatorcontrib>Schepmann, Dirk</creatorcontrib><creatorcontrib>Wünsch, Bernhard</creatorcontrib><creatorcontrib>Carreira, Erick M</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Organic letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Möller, Guido P</au><au>Müller, Steffen</au><au>Wolfstädter, Bernd T</au><au>Wolfrum, Susanne</au><au>Schepmann, Dirk</au><au>Wünsch, Bernhard</au><au>Carreira, Erick M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oxetanyl Amino Acids for Peptidomimetics</atitle><jtitle>Organic letters</jtitle><addtitle>Org. Lett</addtitle><date>2017-05-19</date><risdate>2017</risdate><volume>19</volume><issue>10</issue><spage>2510</spage><epage>2513</epage><pages>2510-2513</pages><issn>1523-7060</issn><eissn>1523-7052</eissn><abstract>Peptides are important in the drug discovery process. In analogy to nonpeptidic small-molecule counterparts, they can sometimes suffer from disadvantages such as their low bioavailability and poor metabolic stability. Herein, we report the synthesis of new oxetanyl dipeptides and their incorporation into Leu-enkephalin analogues as proof-of-principle studies. The modular approach that is described enables the incorporation of a variety of oxetanyl amino acids into potential peptide therapeutics.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>28459595</pmid><doi>10.1021/acs.orglett.7b00745</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0003-1472-490X</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1523-7060 |
| ispartof | Organic letters, 2017-05, Vol.19 (10), p.2510-2513 |
| issn | 1523-7060 1523-7052 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1894518254 |
| source | ACS Publications |
| title | Oxetanyl Amino Acids for Peptidomimetics |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T20%3A05%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oxetanyl%20Amino%20Acids%20for%20Peptidomimetics&rft.jtitle=Organic%20letters&rft.au=Mo%CC%88ller,%20Guido%20P&rft.date=2017-05-19&rft.volume=19&rft.issue=10&rft.spage=2510&rft.epage=2513&rft.pages=2510-2513&rft.issn=1523-7060&rft.eissn=1523-7052&rft_id=info:doi/10.1021/acs.orglett.7b00745&rft_dat=%3Cproquest_cross%3E1894518254%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1894518254&rft_id=info:pmid/28459595&rfr_iscdi=true |